VBI Vaccines Inc. (NASDAQ: VBIV) is -1.45% lower on its value in year-to-date trading and has touched a low of $1.02 and a high of $6.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VBIV stock was last observed hovering at around $2.89 in the last trading session, with the day’s loss setting it -0.18% off its average median price target of $7.50 for the next 12 months. It is also 69.89% off the consensus price target high of $9.00 offered by 4 analysts, but current levels are 54.83% higher than the price target low of $6.00 for the same period.
Currently trading at $2.71, the stock is -11.42% and -19.19% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.41 million and changing -6.39% at the moment leaves the stock -18.96% off its SMA200. VBIV registered 115.08% gain for a year compared to 6-month gain of -4.91%. The firm has a 50-day simple moving average (SMA 50) of $3.1309 and a 200-day simple moving average (SMA200) of $3.0874.
The stock witnessed a -23.45% loss in the last 1 month and extending the period to 3 months gives it a -15.84%, and is -3.90% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.93% over the week and 6.55% over the month.
VBI Vaccines Inc. (VBIV) has around 127 employees, a market worth around $735.30M and $1.10M in sales. Distance from 52-week low is 165.69% and -60.89% from its 52-week high. The company has generated returns on investments over the last 12 months (-23.20%).
VBI Vaccines Inc. (VBIV) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for VBI Vaccines Inc. (VBIV) is a “Buy”. 4 analysts offering their recommendations for the stock have an average rating of 1.20, where 0 rate it as a Hold and 0 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
VBI Vaccines Inc. is expected to release its quarterly report on 08/04/2021 and quarterly earnings per share for the current quarter are estimated at -$0.06 with sales reaching $480k over the same period.The EPS is expected to grow by 53.80% this year, but quarterly earnings will post 376.90% year-over-year.
VBI Vaccines Inc. (VBIV) Top Institutional Holders
177 institutions hold shares in VBI Vaccines Inc. (VBIV), with 8.32M shares held by insiders accounting for 3.28% while institutional investors hold 54.95% of the company’s shares. The shares outstanding are 242.94M, and float is at 178.59M with Short Float at 21.57%. Institutions hold 53.15% of the Float.
The top institutional shareholder in the company is Perceptive Advisors Llc with over 55.04 million shares valued at $151.37 million. The investor’s holdings represent 21.67% of the VBIV Shares outstanding. As of Dec 30, 2020, the second largest holder is State Street Corporation with 22.29 million shares valued at $61.31 million to account for 8.78% of the shares outstanding. The other top investors are Blackrock Inc. which holds 13.18 million shares representing 5.19% and valued at over $36.23 million, while Vanguard Group, Inc. (The) holds 2.17% of the shares totaling 5.51 million with a market value of $15.14 million.
VBI Vaccines Inc. (VBIV) Insider Activity
A total of 0 insider transactions have happened at VBI Vaccines Inc. (VBIV) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider purchase by PERCEPTIVE ADVISORS LLC, the company’s 10% Owner. SEC filings show that PERCEPTIVE ADVISORS LLC bought 9,090,909 shares of the company’s common stock on Apr 24 at a price of $1.10 per share for a total of $10.0 million. Following the purchase, the insider now owns 55.04 million shares.
VBI Vaccines Inc. (VBIV): Who are the competitors?
The company’s main competitors (and peers) include Pieris Pharmaceuticals Inc. (PIRS) that is trading -23.47% down over the past 12 months. Short interest in the company’s stock has risen 5.63% from the last report on Mar 30, 2021 to stand at a total of 38.52 million short shares sold with a short interest ratio of 7.32.